With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
How Large Could The Blow-Fill-Seal Technology Market Become By 2030 At A 12.1% CAGR?
The blow-fill-seal technology market size has seen rapid expansion in recent years. It will grow from $3.94 billion in 2025 to $4.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The historical period’s growth can be attributed to the increasing demand for sterile pharmaceutical packaging, the expansion of injectable drug production, a rising regulatory emphasis on aseptic manufacturing, the growth of liquid pharmaceutical formulations, and the adoption of automated filling technologies.
The blow-fill-seal technology market is anticipated to experience substantial growth over the next few years. It is forecast to expand to $6.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.1%. This expansion during the forecast period is propelled by factors such as increasing production of biologics and vaccines, higher investments in advanced aseptic processing, a growing preference for ready-to-use packaging, the broader application of blow-fill-seal in food and beverage packaging, and a heightened focus on manufacturing efficiency and compliance. Significant trends during this time include the wider adoption of fully automated aseptic packaging lines, an increasing demand for contamination-free manufacturing systems, a growing utilization of single-step container formation processes, the expansion of high-speed blow-fill-seal production capacities, and an enhanced emphasis on packaging solutions that adhere to regulatory requirements.
Get A Free Blow-Fill-Seal Technology Market Sample With 2030 Forecast Insights:
Blow-Fill-Seal Technology Market Outlook: Key Driver Supporting Long-Term Growth
The expanding pharmaceutical industry is anticipated to drive the advancement of the blow-fill-seal technology market. This industry focuses on the research, development, and production of medicines and treatments. Blow-fill-seal (BFS) technology is essential for packaging products, safeguarding them from physical damage, chemical contamination, and microbiological contamination. For instance, in November 2024, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, reported that in 2024, North America accounted for 54.8% of global pharmaceutical sales, while Europe held 22.7%. Thus, the growth of the pharmaceutical industry is fueling the demand for the blow-fill-seal technology market.
Segmentation Of The Blow-Fill-Seal Technology Market: Key Categories Explained
The blow-fill-seal technology market covered in this report is segmented –
1) By Product Type: Bottles, Ampoules, Vials, Prefilled Syringes And Injectables
2) By Material Type: Polyethylene (PE), Polypropylene (PP), Other Materials
3) By Specification: Small Volume, Large Volume
4) By End Use: Pharmaceuticals, Food And Beverage, Cosmetics And Personal Care, Other End Users
Subsegments:
1) By Bottles: Plastic Bottles, Glass Bottles
2) By Ampoules: Glass Ampoules, Plastic Ampoules
3) By Vials: Glass Vials, Plastic Vials
4) By Prefilled Syringes And Injectables: Glass Blow-Fill-Seal (BFS) Prefilled Syringes, Plastic Blow-Fill-Seal (BFS) Prefilled Syringes, Single-Dose Injectable Blow-Fill-Seal (BFS), Multi-Dose Injectable Blow-Fill-Seal (BFS)
Blow-Fill-Seal Technology Market Evolving Trends: What Businesses Should Know
Leading companies in the blow-fill-seal technology market are concentrating on developing innovative solutions, such as closed-parison aseptic BFS platforms, to address the increasing demand for high-purity sterile packaging, flexible small-volume parenteral production, and contamination-free drug delivery systems for vaccines, biologics, and ophthalmic formulations. A closed-parison aseptic BFS platform is defined as a Blow-Fill-Seal system where the plastic parison, the molten tube that forms the container, is entirely enclosed during its formation and filling. This creates a sealed Grade A sterile environment, which prevents external contamination, improves sterility assurance, enhances compliance with strict GMP requirements, and supports the safe processing of sensitive products like vaccines, biologics, and ophthalmic formulations. For instance, in October 2024, Brevetti Angela Srl, an Italy-based manufacturing company, introduced the SYFPAC DUO BFS platform, an advanced aseptic packaging system that premiered at the 2024 CPHI Worldwide Pharma Expo in Milan. This system features an ultra-compact 6 m² footprint and offers a scalable output ranging from 4,000 to 40,000 units per hour, providing one of the highest productivity-to-size ratios available in the market. It incorporates Closed Parison technology, enabling sterile container formation and filling under stringent EU GMP Annex 1 conditions, alongside Insertion Technology for the cost-effective production of prefilled syringes, multidose droppers, and other delivery devices. The DUO platform supports PE, HDPE, and PP materials with rapid mould changeovers, minimizes plastic scrap to below 6%, and facilitates cold-temperature production of vaccines and biologics below 25°C, capabilities previously unprecedented in a closed-parison BFS machine.
Who Competes In The Blow-Fill-Seal Technology Market? Major Companies Listed
Major companies operating in the blow-fill-seal technology market are Amanta Healthcare Ltd.; Unither Pharmaceuticals SAS; Weiler Engineering Inc.; GlaxoSmithKline PLC; Nephron Pharmaceuticals Corporation; Brevetti Angela SRL; Recipharm AB; Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH; Unicep Packaging LLC; Catalent Inc.; The Ritedose Corporation; Birgi Mefar Group; Takeda Pharmaceutical Company Limited; Pfizer Inc.; Sanofi SA; Novartis International AG; Merck & Co. Inc.; Johnson & Johnson Private Limited; Teva Pharmaceutical Industries Ltd.; AstraZeneca PLC; F Hoffmann-La Roche Ltd.; Fresenius Kabi AG; B. Braun Melsungen AG; Sandoz International GmbH; Baxter International Inc.; West Pharmaceutical Services Inc.; Gerresheimer AG
Read The Complete Blow-Fill-Seal Technology Market Forecast Report Through 2030:
Blow-Fill-Seal Technology Market Regional Ranking: Which Geography Comes First?
North America was the largest region in the blow-fill-seal technology market in 2025. The regions covered in the blow-fill-seal technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
